Diabetes, Gestational Clinical Trial
Official title:
Outpatient Cervical Ripening and Labor Induction With Orally Administered Misoprostol for Term Pregnancies Complicated by Diabetes Mellitus
Verified date | September 2023 |
Source | MemorialCare Health System |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A. Null Hypothesis: In term pregnancies complicated by diabetes, there is no difference in the time interval from start of induction to delivery when outpatient cervical ripening and labor induction is initiated with orally administered misoprostol, a prostaglandin El analogue, compared to placebo. B. Specific aims: 1. Demonstrate that oral misoprostol is effective for cervical ripening compared to placebo when given in an outpatient basis to women with pregnancies complicated by diabetes mellitus. 2. Demonstrate that oral misoprostol can be administered safely in an outpatient setting. The patients will be observed for a period of four hours in an outpatient antepartum testing unit after the medication is administered to demonstrate fetal well being and verify that there is no evidence of uterine hyperstimulation. (We acknowledge that markers of serious adverse maternal and neonatal outcomes are rare, and can only be adequately addressed in large multicenter trials.) 3. Assess the cost differential in inpatient and outpatient utilization of misoprostol for cervical ripening and labor induction. In order to estimate the impact that outpatient cervical ripening may have on total hospitalization costs, we will use daily hospital charges and published data regarding pharmaceutical costs.
Status | Terminated |
Enrollment | 5 |
Est. completion date | December 2008 |
Est. primary completion date | December 2008 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: 1. Singleton gestation 2. Intact membranes 3. Bishop score <= 4 4. Uterine contractions <=12/hour 5. Cephalic presentation 6. Estimated gestational age of at least 38 weeks by ACOG dates 7. An amniotic fluid index (AFI) >5 cm 8. Reactive Non Stress Test 9. Class A1, A2 diabetes 10. Good compliance with clinic visits and home glucose monitoring Exclusion Criteria: I. Fetal Factors 1. Multiple Gestation 2. Presence of fetal distress/non-reassuring FHR pattern 3. Malpresentation, including breech 4. EFW > 4500 gm or other evidence of cephalo-pelvic disproportion 5. EFW < 2000 gm II. Maternal Factors 1. Frequent uterine contractions >= 12/hour 2. Ruptured membranes 3. Placenta previa or unexplained vaginal bleeding 4. Vasa previa 5. Active herpes simplex 6. Glaucoma or elevated intraocular pressure 7. Renal or hepatic dysfunction 8. Previous Cesarean delivery or history of uterine surgery 9. Evidence of chorioamnionitis or maternal fetal >= 100.4 degrees F 10. Significant cardiac lesion or cardiovascular disease 11. Severe asthma 12. Parity >=6 |
Country | Name | City | State |
---|---|---|---|
United States | Long Beach Memorial Medical Center | Long Beach | California |
Lead Sponsor | Collaborator |
---|---|
MemorialCare Health System | Long Beach Memorial Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Primary Outcome Measure Will be the Time Interval From Start of Induction to Delivery. | Demonstrate that oral misoprostol is effective for cervical ripening compared to placebo when given in an outpatient basis to women with pregnancies complicated by diabetes mellitus. The study was terminated, and no study data and/or analyzed. No study data are available. |
induction to delivery | |
Secondary | Demonstrate That Oral Misoprostol Can be Administered Safely in an Outpatient Setting. | The study was terminated, and no study data and/or analyzed. No study data are available. | The PI has left the institution. Efforts were exhausted in attempting to contact the PI/study team members. No study data are available. | |
Secondary | Other Outcome Measures Will be Number of Doses of Medication Required, Oxytocin Requirements, and Route of Delivery. | No data was collected. | induction to delivery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Completed |
NCT01940003 -
Effects of an Aquatic Physical Exercise Program on Glycaemic Control and Perinatal Outcomes of Gestational Diabetes: Study Protocol for a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02960295 -
The Virtual Visit for Women With Gestational Diabetes
|
N/A | |
Completed |
NCT01919476 -
Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women
|
N/A | |
Completed |
NCT05512871 -
A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM)
|
N/A | |
Enrolling by invitation |
NCT03307486 -
Gestational Diabetes: a Cohort Study
|
N/A | |
Active, not recruiting |
NCT04417452 -
Long-term Outcome After Gestational Diabetes and Diabetes in Pregnancy
|
||
Completed |
NCT02968628 -
Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
|
||
Active, not recruiting |
NCT04222348 -
MeDiGes Study: Metformine Use in Gestational Diabetes
|
Phase 3 | |
Completed |
NCT03007186 -
Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus
|
||
Completed |
NCT00069576 -
Gestational Diabetes Mellitus Trial (GDM)
|
N/A | |
Completed |
NCT04866823 -
Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes
|
N/A | |
Recruiting |
NCT04198857 -
Development and Testing of a Mobile Health Application for Management of Gestational Diabetes
|
N/A | |
Recruiting |
NCT05115188 -
DIAgnosing GDM usiNg Oral Sugar InStead
|
Phase 2 | |
Recruiting |
NCT03607799 -
A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes
|
N/A | |
Recruiting |
NCT02893072 -
Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study
|
N/A | |
Enrolling by invitation |
NCT05368220 -
Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
|
||
Completed |
NCT02770079 -
Insulin Sensitivity and Secretion During Pregnancy and Post Partum in Women With Gestational Diabetes.
|
||
Completed |
NCT00681460 -
Metformin in Gestational Diabetes Mellitus
|
N/A | |
Recruiting |
NCT03117543 -
Diagnostic Approaches in Gestational Diabetes and Impact of Ethnicity
|